[A case of mucocutaneous leishmaniasis treated with success with a low dose of pentavalent antimonial]

Rev Soc Bras Med Trop. 1998 Mar-Apr;31(2):221-4. doi: 10.1590/s0037-86821998000200008.
[Article in Portuguese]

Abstract

The authors report a case of a 89 years-old woman with mucocutaneous leishmaniasis and previous diabetes mellitus and high blood pressure, who had been treated with allopurinol for 10 months without healing of lesions. Afterwards, she has been treated with meglumine antimonate, "glucantime" for 4 days, with a total dose 2,380 mg of Sbv, but developed cardiac side effects and hypokalemia, hence the treatment was withdrawn. However, this patient developed total clinical regression of lesions, in spite of she has been received low dose of this drug.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Aged, 80 and over
  • Antiprotozoal Agents / administration & dosage*
  • Facial Dermatoses / blood
  • Facial Dermatoses / drug therapy*
  • Facial Dermatoses / parasitology
  • Female
  • Humans
  • Leishmaniasis, Mucocutaneous / blood
  • Leishmaniasis, Mucocutaneous / drug therapy*
  • Meglumine / administration & dosage*
  • Meglumine Antimoniate
  • Organometallic Compounds / administration & dosage*

Substances

  • Antiprotozoal Agents
  • Organometallic Compounds
  • Meglumine
  • Meglumine Antimoniate